Caplin Point Laboratories Limited (CAPLIPOINT) — Financial Results

· NSE Neutral
📢 Key Event
Trading window closed from April 1, 2026, pending FY2026 audited financial results declaration.
🔮 What's Next
Trading window to reopen 48 hours after FY2026 financial results are declared to stock exchanges.
💡 Investor Takeaway
Shareholders cannot trade company securities from April 1 until 48 hours post-results announcement due to regulatory compliance requirements.

Caplin Point Laboratories Limited announced closure of its trading window effective April 1, 2026, in accordance with SEBI insider trading regulations. The closure is tied to finalization of audited financial statements for the fiscal year ending March 31, 2026. The trading window will reopen 48 hours after financial results are declared to stock exchanges.

📄 View Original Announcement (PDF)

About Caplin Point Laboratories Limited (CAPLIPOINT)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹15,193.22 Cr P/E: 29.5

View full CAPLIPOINT stock details →

📡 Get AI alerts when CAPLIPOINT files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAPLIPOINT — Free

📊 More CAPLIPOINT filings

See all CAPLIPOINT filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when CAPLIPOINT files new disclosures

Track CAPLIPOINT filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAPLIPOINT — Free

Free account · 2 AI queries/day